NEWS - Press release
- Ny administrerende direktør i Inven2 AS Ole Kristian Hjelst ...
- Oxford Gene Technology Signs Licensing Deal for Colorectal Cancer Biomarkers Oxford, UK – 22nd ...
- AIMS Innovation - provider of proactive Microsoft Biztalk monitoring - announces completion of first round seed funding Oslo, Norway, ...
NEWS - Twitter
-
Inven2 has today licensed an antibody from Oslo university hospital to a German company.
-
Ny administrerende direktør tiltrer i Inven2. Les mer på http://t.co/iJTT7Lb3
-
Oxford Gene Technology licenses panel of biomarkers to diagnose colorectal cancer, learn more at http://t.co/Kl2xcoPP
